Gonorrhea clinical trials
12 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- Effectiveness of Relationship Education for Reducing HIV Incidence Among Men Who Have Sex With Men
- Point of Care STI Testing
- Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
- A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities
- Improving Maternal and Child Health Through Point-of-care STI Testing
- Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
- SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection
- Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision
- Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
- Improving Clinic Delivery of HIV-related Anal Health Services
- Clinical Evaluation of the ID NOW™ CT/NG Test
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Gonorrhea” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.